hold on there's just too much going on in Congress lmao...
Prohibits selling mislabeled dietary supplements or those made by banned individuals.
Senators Durbin (D-IL) and Blumenthal (D-CT) introduced it.
In committee, no Senate vote yet
This bill amends federal law to prevent certain dietary supplements from being sold. It would stop products marketed as supplements that don't meet the legal definition, and prevent supplements from being made by individuals banned from the industry. Senators Durbin and Blumenthal introduced it, and it's currently under review in a Senate committee.
Introduced Feb 5, 2026
This bill was introduced in the Senate on February 5, 2026, and has been sent to the Committee on Health, Education, Labor, and Pensions for review. For it to become law, it needs to be approved by this committee, pass a vote in the full Senate, then pass a vote in the House of Representatives, and finally be signed by the President.
If this bill passes, consumers might find that dietary supplements on the market are more reliably what they claim to be, as products that don't meet the legal definition of a supplement would be prohibited. It would also help ensure that supplements are not prepared or handled by individuals banned from the industry for past violations, potentially increasing product safety. Federal authorities would also gain stronger powers to stop and seize non-compliant supplements from being sold or imported.
Supporters Say
Supporters argue the bill is crucial for protecting public health by preventing the sale of dangerous or mislabeled dietary supplements.
Critics Say
Critics might raise concerns about the interpretation of new definitions, potentially affecting a wider range of products than intended.
Supporters emphasize that this legislation would close loopholes that allow harmful substances, like those often marketed as "gas station heroin," to be sold under the guise of dietary supplements. They believe it strengthens FDA's ability to ensure product integrity and consumer safety. Critics, though not explicitly stated in the bill, typically voice concerns that broad language could unintentionally sweep in legitimate products or that increased regulatory powers could stifle innovation in the supplement market.